James Thrasher, MD
Enriched profilePresident and Endocrinologist, Arkansas Diabetes and Endocrinology Center · Arkansas Diabetes and Endocrinology Center
James Thrasher is President and Endocrinologist, Arkansas Diabetes and Endocrinology Center at Arkansas Diabetes and Endocrinology Center. ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 12 Oct 2026
Overview
Updated 16 Oct 2026
James Thrasher, M.D., is President and Endocrinologist, Arkansas Diabetes and Endocrinology Center. The public record shows 36 publications with 5,387 citations (h-index 20), centered on Type 1 Diabetes. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 41 companies.
- Top research focus: Type 1 Diabetes
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 41 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Sponsor: Medtronic MiniMed, Inc.
- A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Sponsor: Zucara Therapeutics Inc.
- Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®
Sponsor: Medtronic MiniMed, Inc.
Industry payments
Updated 16 Oct 2026
41 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202534 payments
- Eli Lilly and CompanyProgram year20251 payment
- Novo Nordisk IncProgram year20256 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
68.6%Insulin Analog22.1%Lantus Solostar20%Novolog11%Insulin Lispro10%Basaglar Kwikpen U-1008%Tresiba Flextouch U-1007%Toujeo Max Solostar6%Humalog6%Novolog Flexpen6%Humalog Kwikpen U-1005%Insulin Lispro Kwikpen U-1003%Lantus3%Fiasp Flextouch3%Fiasp3%Humalog Kwikpen U-2002%Toujeo Solostar2%Levemir Flexpen2%Tresiba Flextouch U-2002%Lyumjev1%Lyumjev Kwikpen U-1001%Admelog Solostar1%Soliqua 100-331%Insulin Aspart1%Admelog1%Part D<11 patientsGLP-1 receptor agonist19.4%Ozempic61%Mounjaro30%Trulicity8%Rybelsus1%Part D<11 patients+ 9 more classes in this area
Hormonal (systemic)
16.8%l-Thyroxine13.6%Levothyroxine Sodium84%Synthroid16%Part D≥240 patientsl-Triiodothyronine1.5%Liothyronine Sodium100%Part D≥41 patients+ 5 more classes in this area
Cardiovascular
11.7%Statin5.2%Atorvastatin Calcium60%Rosuvastatin Calcium19%Pravastatin Sodium15%Simvastatin7%Part D<11 patientsACE inhibitor1.8%Lisinopril79%Ramipril13%Lisinopril-Hydrochlorothiazide8%Part D<11 patients+ 12 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor
Diabetes Technology & Therapeutics
2025 - Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States
Diabetes Technology & Therapeutics
2024
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
University of Arkansas for Medical Sciences College of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →threebestrated.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →threebestrated.com ↗
Editorial & leadership roles
journal and society appointments- Member
American Diabetes Association (ADA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cslide.ctimeetingtech.com ↗ - Member
American Association of Clinical Endocrinologists (AACE)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cslide.ctimeetingtech.com ↗ - Fellow
American College of Endocrinology (FACE)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →threebestrated.com ↗ - Data Monitoring Board
Medtronic Closed Loop studies
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cslide.ctimeetingtech.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →threebestrated.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →threebestrated.com ↗
- Center of Excellence
Sanofi and Medtronic
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cslide.ctimeetingtech.com ↗
Secondary affiliations
appointments beyond the home institution- President and Lead Research Scientist
Medical Investigations, Inc.
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cslide.ctimeetingtech.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine